Trebananib
Modify Date: 2025-08-27 13:06:06
Trebananib structure
|
Common Name | Trebananib | ||
|---|---|---|---|---|
| CAS Number | 894356-79-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TrebananibTrebananib (2xCon4C; AMG 386), a non-VEGF-dependent angiogenesis pathway inhibitor, is a peptide-Fc fusion protein that neutralises the interaction between angiopoietins-1/2 and the Tie2 receptor, plus FOLFIRI. Trebananib can be used to research anticancer and ocular neovascular diseases[1][2]. |
| Name | AMG-386,Trebananib |
|---|
| Description | Trebananib (2xCon4C; AMG 386), a non-VEGF-dependent angiogenesis pathway inhibitor, is a peptide-Fc fusion protein that neutralises the interaction between angiopoietins-1/2 and the Tie2 receptor, plus FOLFIRI. Trebananib can be used to research anticancer and ocular neovascular diseases[1][2]. |
|---|---|
| Related Catalog |
| No Any Chemical & Physical Properties |